Jha et al. (39) found that JAK2/STAT3 activation supports PD-L1 expression, promoting survival, invasion, metastasis, and chemoresistance in oral squamous cell carcinoma. The gene discussed is JAK2; the disease is oral cavity squamous cell carcinoma.